5F-NNE1
From Infogalactic: the planetary knowledge core
Systematic (IUPAC) name | |
---|---|
1-(5-Fluoropentyl)-N-(naphthalen-1-yl)-1H-indole-3-carboxamide
|
|
Clinical data | |
Legal status |
|
Identifiers | |
CAS Number | 1445580-60-8 |
ChemSpider | 29341632 |
UNII | 3T22QDP4D9 |
Chemical data | |
Formula | C24H23FN2O |
Molecular mass | 374.45 g/mol |
|
|
|
5F-NNE1 (also known as 5F-NNEI and 5F-MN-24) is an indole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.[1][2] Given the known metabolic liberation (and presence as an impurity) of amantadine in the related compound APINACA, it is suspected that metabolic hydrolysis of the amide group of 5F-NNE1 may release 1-naphthylamine, a known carcinogen.
Legality
Sweden's public health agency suggested classifying 5F-NNE1 as hazardous substance on November 10, 2014.[3]
See also
<templatestyles src="Div col/styles.css"/>
References
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugboxes with an unspecified ATC code
- Articles containing unverified chemical infoboxes
- Cannabinoids
- Designer drugs
- Organofluorides
- Indolecarboxamides
- Naphthoylindoles
- Cannabinoid stubs